Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Cash flows from operating activities:
Net income	$ 37.5	$ 98.4	$ 104.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	63.8	51.6	54.4
Stock-based compensation expense	11.6	8.6	8.9
Amortization of debt issuance costs	0.6	0.5	0.5
Benefit for deferred income taxes	(7.9)	(4.5)	(1.4)
Amortization of acquisition-related inventory step-up	0.0	0.0	0.6
Forward contract (gains) losses, net	0.3	(4.0)	(4.7)
Other, net	0.0	0.0	0.1
(Increase) decrease in, net of acquisition:
Accounts receivable	16.3	9.1	(32.4)
Inventories	(17.9)	(27.0)	(52.5)
Income taxes receivable	0.3	(5.0)	(0.7)
Other current assets	(5.5)	1.6	0.7
Other assets	(3.8)	8.0	5.1
Increase (decrease) in, net of acquisition:
Accounts payable	(5.2)	(11.5)	23.8
Accrued expenses and other liabilities	(5.8)	(6.2)	8.1
Income taxes payable	(1.6)	(2.3)	5.7
Other noncurrent liabilities	3.9	(7.4)	(7.7)
Contingent consideration payments in excess of acquisition date fair value	(2.7)	0.0	0.0
Net cash provided by operating activities	83.9	109.9	113.1
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(114.2)	(67.3)	(61.1)
Capital expenditures	(34.3)	(31.9)	(26.8)
Proceeds from dispositions of property, plant and equipment	0.3	7.2	0.2
Cash settlement of forward contracts	0.4	4.3	2.4
Software development costs	(6.1)	(3.1)	(2.6)
Amounts paid for net assets acquired	0.0	0.0	(2.4)
Net cash used in investing activities	(153.9)	(90.8)	(90.3)
Cash flows from financing activities:
Borrowings on revolving credit facilities	189.2	118.7	81.2
Repayment of borrowings on revolving credit facilities	(252.0)	(92.7)	(86.8)
Borrowings on long-term non-revolving debt	160.0	0.0	12.0
Repayment of borrowings on long-term non-revolving debt	(21.5)	(18.0)	(16.2)
Proceeds from stock issued	2.0	2.1	1.8
Dividends to shareholders	(11.8)	(11.7)	(11.6)
Payment of employee tax withholding on equity award vestings	(2.2)	(2.6)	(1.4)
Payment of contingent consideration liability	(3.4)	(1.0)	(0.3)
Other financing activities	(2.4)	(1.7)	(1.3)
Net cash (used in) provided by financing activities	57.9	(6.9)	(22.6)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.8	3.0	3.0
Net increase (decrease) in cash, cash equivalents and restricted cash	(11.3)	15.2	3.2
Cash, cash equivalents and restricted cash, beginning of period	43.7	28.5	25.3
Cash, cash equivalents and restricted cash, end of period	32.4	43.7	28.5
Cash paid:
Income taxes	26.4	31.7	23.6
Interest	29.5	15.5	15.9
Supplemental disclosure of noncash transactions:
Unrealized (gain) loss on interest rate swap	4.4	(12.8)	(6.0)
Contingent consideration incurred in connection with acquisition	0.0	0.0	3.3
Stock issued for acquisition	18.7	1.6	14.2
Foreign currency remeasurement impact on euro denominated debt	(2.4)	4.6	5.9
Measurement period adjustment	$ 0.0	$ 0.0	$ 0.8